In this episode, Marc Bloomenstein, OD, FAAO, talks with Mitch Ibach, OD, FAAO, who practices at Vance Thompson Vision, in Sioux Falls, South Dakota, an OD-MD tertiary referral center. The pair opened the conversation with what’s new and exciting in patient care, including a newly-approved presbyopia combination drop, carbachol and brimonidine tartrate (Yuvezzi, Tenpoint Pharmaceuticals). Dr. Ibach then shared a few developments coming out of Vance Thompson, including an ocular IOP-adjusting pump for significant glaucomatous disease and the benefits of cultured endothelial cells for Fuchs dystrophy.
COLLAB CORNER - What’s Coming Down the Pipeline in Patient Care

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In this episode, Marc Bloomenstein, OD, FAAO, talks with Mitch Ibach, OD, FAAO, who practices at Vance Thompson Vision, in Sioux Falls, South Dakota, an OD-MD tertiary referral center. The pair opened the conversation with what’s new and exciting in patient care, including a newly-approved presbyopia combination drop, carbachol and brimonidine tartrate (Yuvezzi, Tenpoint Pharmaceuticals). Dr. Ibach then shared a few developments coming out of Vance Thompson, including an ocular IOP-adjusting pump for significant glaucomatous disease and the benefits of cultured endothelial cells for Fuchs dystrophy.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

